Literature DB >> 31353083

Silencing of the transcription factors Oct4, Sox2, Klf4, c-Myc or Nanog has different effect on teratoma growth.

Emilly Schlee Villodre1, Karina Bettega Felipe2, Mayumi Zanotta Oyama1, Francine Hehn de Oliveira3, Patrícia Luciana da Costa Lopez4, Claudia Solari5, Gustavo Sevlever6, Alejandra Guberman7, Guido Lenz8.   

Abstract

Induced pluripotent stem cells (iPSC) have a great potential, but their clinical application depends on finding strategies to abolish their tumorigenic potential. The use of Oct4, Sox2, Klf4, c-Myc and Nanog to generate iPSC demonstrated the already known importance of these genes to maintain stemness. Therefore, the presence of these genes is responsible for iPSC-derived teratomas. Similar to iPSC, P19 teratocarcinoma cell line also has characteristics of embryonic carcinoma cells and the ability to differentiate into many cell types. We separately silenced the transcription factors Oct4, Sox2, Klf4, c-Myc and Nanog in P19 cells and measured the impact of this silencing in vivo. All silenced cells generated tumors when injected in immunosuppressed mice, but silencing of Oct4, Sox2 and Klf4 generated mainly teratomas with mesoderm tissue. Our results suggest that downregulation of these transcription factors is not enough to avoid the formation of teratomas, but their silencing affect their differentiation potential.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Embryonic stem cell; Knockdown; P19 cell line; Teratocarcinoma; Yamanaka factors

Mesh:

Substances:

Year:  2019        PMID: 31353083     DOI: 10.1016/j.bbrc.2019.07.064

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

Review 1.  Evidence for immortality and autonomy in animal cancer models is often not provided, which causes confusion on key issues of cancer biology.

Authors:  Xixi Dou; Pingzhen Tong; Hai Huang; Lucas Zellmer; Yan He; Qingwen Jia; Daizhou Zhang; Jiang Peng; Chenguang Wang; Ningzhi Xu; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2020-03-04       Impact factor: 4.207

Review 2.  Mutation or not, what directly establishes a neoplastic state, namely cellular immortality and autonomy, still remains unknown and should be prioritized in our research.

Authors:  Shengming Zhu; Jiangang Wang; Lucas Zellmer; Ningzhi Xu; Mei Liu; Yun Hu; Hong Ma; Fei Deng; Wenxiu Yang; Dezhong Joshua Liao
Journal:  J Cancer       Date:  2022-07-04       Impact factor: 4.478

3.  MiR-106b-5p Regulates the Reprogramming of Spermatogonial Stem Cells into iPSC (Induced Pluripotent Stem Cell)-Like Cells

Authors:  Amir Hossein Hasani Fard; Mahmoud Valizadeh; Zohreh Mazaheri; Jalil Hosseini
Journal:  Iran Biomed J       Date:  2022-07-01

4.  Proteomic analysis of the IPF mesenchymal progenitor cell nuclear proteome identifies abnormalities in key nodal proteins that underlie their fibrogenic phenotype.

Authors:  Libang Yang; Adam Gilbertsen; Karen Smith; Hong Xia; LeeAnn Higgins; Candace Guerrero; Craig A Henke
Journal:  Proteomics       Date:  2022-06-14       Impact factor: 5.393

Review 5.  Pluripotent Stem Cells: Cancer Study, Therapy, and Vaccination.

Authors:  Mojgan Barati; Maryam Akhondi; Narges Sabahi Mousavi; Newsha Haghparast; Asma Ghodsi; Hossein Baharvand; Marzieh Ebrahimi; Seyedeh-Nafiseh Hassani
Journal:  Stem Cell Rev Rep       Date:  2021-06-11       Impact factor: 5.739

6.  The Na+/K+ ATPase Inhibitor Ouabain Attenuates Stemness and Chemoresistance of Osteosarcoma Cells.

Authors:  Weixiong Guo; Bo Wei; Tingting Cheng; Xiaotao Xu; Feiling Ruan; Min Xiang
Journal:  Med Sci Monit       Date:  2019-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.